Low-cap pot: Small cannabis companies
23 No. of Symbols
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0245 USD
−9.87 M USD
24.95 M USD
388.53 M
About MEDIPHARM LABS CORP
Sector
Industry
CEO
David A. Pidduck
Website
Headquarters
Barrie
Founded
2015
FIGI
BBG00M61H441
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company focuses on the downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. It supplies raw materials, formulations, processing, and packaging for the creation of ready-to-sell derivative products. The company was founded by Patrick McCutcheon in 2015 and is headquartered in Barrie, Canada.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where MEDIF is featured.
Frequently Asked Questions
The current price of MEDIF is 0.0464 USD — it has decreased by −1.39% in the past 24 hours. Watch Medipharm Labs Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Medipharm Labs Corporation stocks are traded under the ticker MEDIF.
MEDIF stock has fallen by −4.42% compared to the previous week, the month change is a −3.40% fall, over the last year Medipharm Labs Corporation has showed a −8.66% decrease.
MEDIF reached its all-time high on May 22, 2019 with the price of 5.6500 USD, and its all-time low was 0.0374 USD and was reached on Aug 5, 2024. View more price dynamics on MEDIF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MEDIF stock is 18.22% volatile and has beta coefficient of 1.06. Track Medipharm Labs Corporation stock price on the chart and check out the list of the most volatile stocks — is Medipharm Labs Corporation there?
Today Medipharm Labs Corporation has the market capitalization of 20.76 M, it has decreased by −7.02% over the last week.
Yes, you can track Medipharm Labs Corporation financials in yearly and quarterly reports right on TradingView.
Medipharm Labs Corporation is going to release the next earnings report on Nov 12, 2024. Keep track of upcoming events with our Earnings Calendar.
MEDIF earnings for the last quarter are −0.01 USD per share, whereas the estimation was −0.01 USD resulting in a −27.39% surprise. The estimated earnings for the next quarter are 0.00 USD per share. See more details about Medipharm Labs Corporation earnings.
Medipharm Labs Corporation revenue for the last quarter amounts to 7.56 M USD, despite the estimated figure of 7.50 M USD. In the next quarter, revenue is expected to reach 9.05 M USD.
MEDIF net income for the last quarter is −1.89 M USD, while the quarter before that showed −2.67 M USD of net income which accounts for 29.20% change. Track more Medipharm Labs Corporation financial stats to get the full picture.
No, MEDIF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 8, 2024, the company has 166.00 employees. See our rating of the largest employees — is Medipharm Labs Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Medipharm Labs Corporation EBITDA is −8.98 M USD, and current EBITDA margin is −49.46%. See more stats in Medipharm Labs Corporation financial statements.
Like other stocks, MEDIF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Medipharm Labs Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Medipharm Labs Corporation technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Medipharm Labs Corporation stock shows the sell signal. See more of Medipharm Labs Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.